Document Page: First | Prev | Next | All | Image | This Release | Search
File: 123096_sep96_decls4_0001.txt
Subject: TREATMENT OF NAPP OVERDOSE 26 DEC 90
Unit: VAR. BUMED
Parent Organization: BUMED
Box ID: BX303902
Folder Title: TREATMENT OF NERVE AGENT PYRIDOSTIGMINE PRETREATMENT OVERDOSE
Document Number: 1
Folder Seq #: 7
UNCLASSIFIED
UNITED STATES MARINE CORPS
3RD Marine Aircraft Wing, FMFPAC
FPO San Francisco, CA 96608-6001
6000
MED
26 Dec 90
MEMORANDUM
From: Wing Surgeon, Third Marine Aircraft Wing, FMFPAC
To: Distribution
Subj: TREATMENT OF NERVE AGENT PYRIDOSTIGMINE PRETREATMENT
(NA,PP) OVERDOSE
Ref: (a) Phone conversation between CDR Clark, 3rd KAW
Medical, and COL Wade, CENTCOM Medical, IS Dec 90.
1. Nerve Agent Pyridostignine Pretreatment (NAPP) consist of,a,
blister pack of twenty-one (21) 30mg Pyridostigmine tablets.
2. Pyri(;ostigmine, taken in advance of exposure to chemical
agents, enhances the antidote effectiveness of the Mark 1
Antidote Kits. The Pyrodostigmine dose should never exceed one
(1) tablet (30mg) in any 8-hour period. Although rare at this
dosage, minor side effects may be encountered (increased
flatus, loose stools, and slight drop in heart rate). If
tablets are taken more frequently than every eight (8) hours or
more than one at a time, symptoms similar to nerve agent
exposure wiii appear but are reversible with timely medical
treatment.
3. Although there is no recognized abuse potential, it is
possible that NAPP could be taken as a suicide gesture/attempt.
As stated above, signs and symptoms would be similar to nerve
agent exposure, characterized by parasympathetic hyperactivity
amps, nausea, vomiting,
salivation, lacrimation, tracheobronchial secretions,
urination, excessive sweating, bronchoconstriction,
bradycardia, AV conduction slowing, weakness, and pinpoint
pupils), but CNS effects should not be a problem unless
respiratory arrest from neuromuscular paralysis has resulted in
coma leading to secondary CNS effects. Although not verified
at this time, experts in chemical warfare are of the opinion
that pyridostigmine overdose may induce vomiting and thereby
limit the problem by evacuating the stomach of the ingested
Pyridoktigmine (reference (a)).
4. Pyridostigmine reaches peak level@-in blood at
approximately 4 hours and has a half life of 6 hours.
Depending on the amount of overdose, Pyridostignine could
persist in the blood to some degree as long as 24-36 hours.
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 2 f:/Week-44/BX303902/TREATMENT OF NERVE AGENT PYRIDOSTIGMINE PRETREATMENT OVERDOSE/treatment of napp overdose 26 dec 90:1217960956163
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-44
Box ID = BX303902
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = TREATMENT OF NERVE AGENT PYRIDOSTIGMINE PRETREATMENT OVERDOSE
Folder Seq # = 7
Subject = TREATMENT OF NAPP OVERDOSE 26 DEC 90
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996